BioNexus Gene Lab Corp (BGLC) grants CEO 338,709 fully vested shares
BioNexus Gene Lab Corp (BGLC) announced that its CEO and director, Tan Lee Su-Leng, received a fully vested stock award of 338,709 common shares. These shares, granted under the company's 2025 Equity Incentive Plan for completed services, were valued at $1.55 per share based …